dc.creator | Bollini, Mariela | |
dc.creator | Cisneros, José A. | |
dc.creator | Spasov, Krasimir A. | |
dc.creator | Anderson, Karen S. | |
dc.creator | Jorgensen, William L. | |
dc.date.accessioned | 2017-09-21T21:16:33Z | |
dc.date.accessioned | 2018-11-06T13:46:28Z | |
dc.date.available | 2017-09-21T21:16:33Z | |
dc.date.available | 2018-11-06T13:46:28Z | |
dc.date.created | 2017-09-21T21:16:33Z | |
dc.date.issued | 2013-07 | |
dc.identifier | Bollini, Mariela; Cisneros, José A.; Spasov, Krasimir A.; Anderson, Karen S.; Jorgensen, William L.; Optimization of diarylazines as anti-HIV agents with dramatically; Elsevier; Bioorganic & Medicinal Chemistry Letters; 23; 18; 7-2013; 5213-5216 | |
dc.identifier | 0960-894X | |
dc.identifier | http://hdl.handle.net/11336/24881 | |
dc.identifier | CONICET Digital | |
dc.identifier | CONICET | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1879184 | |
dc.description.abstract | Non-nucleoside inhibitors of HIV-1 reverse transcriptase are reported that have ca. 100-fold greater solubility than the structurally related drugs etravirine and rilpivirine, while retaining high anti-viral activity. The solubility enhancements come from strategic placement of a morpholinylalkoxy substituent in the entrance channel of the NNRTI binding site. Compound 4d shows low-nanomolar activity similar to etravirine towards wild-type HIV-1 and key viral variants. | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bmcl.2013.06.091 | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0960894X1300824X | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759246/ | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Anti-HIV agent | |
dc.subject | NNRTI | |
dc.subject | Drug solubility | |
dc.title | Optimization of diarylazines as anti-HIV agents with dramatically | |
dc.type | Artículos de revistas | |
dc.type | Artículos de revistas | |
dc.type | Artículos de revistas | |